CureDuchenne Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

CureDuchenne Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 25, 2023	Myosana Therapeutics	$5.0M Seed	John Ballantyne	Sharon Hesterlee, Parent Project Muscular Dystrophy
Jun 1, 2022	Code Biotherapeutics	$75.0M Series A	Northpond Ventures	4BIO Capital, F-Prime Capital Partners, Generation Ventures, Ed Mathers, New Enterprise Associates, RiverVest, Takeda Ventures, Amgen Ventures, Hatteras Venture Partners, JDRF T1D Fund, UCB Ventures, UPMC Enterprises
Aug 5, 2021	Pepgen	$112.5M Other Equity	—	Adage Capital Management, Deerfield Management, Gray's Creek Capital Partners, Laurion Capital Management, Alexis Dormandy, Joshua Resnick, Samsara BioCapital, Tudor Ventures, Viking Global Investors
Apr 1, 2021	Code Biotherapeutics	$10.0M Seed	4BIO Capital, Rob Lin, PhD, CFA	F-Prime Capital Partners, Generation Ventures, Ed Mathers, New Enterprise Associates, Northpond Ventures, RiverVest, Takeda Ventures, Debra Miller, JDRF T1D Fund
Mar 31, 2021	Entrada Therapeutics	$116.0M Series B	Wellington Management	Kush Parmar, Agent Capital, Goldman Sachs, Greenspring Associates, MPM Capital, MRL Ventures Fund, Point72, Qatar Investment Authority, Redmile Group, Roche, TCGX, Undisclosed Global Investment Firm
Dec 1, 2020	Edgewise Therapeutics	$95.0M Series C	Viking Global Investors	5AM Ventures, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, The Column Group, U.S. Venture Partners, Cormorant Asset Management, Deerfield Management, Janus Henderson Investors, Logos Capital, New Leaf Ventures, Novo Holdings, RA Capital Management, Surveyor Capital, Wellington Management
Dec 1, 2020	Pepgen	$45.0M Series A	Ramin Farzaneh-Far	MPM Capital, RA Capital, Vida Ventures, Debra Miller, Uciane Scarlett, Matthew Wood
Apr 22, 2020	Myosana Therapeutics	$1.0M Seed	Debra Miller	—
Nov 13, 2019	Avidity Biosciences	$100.0M Series C	Roderick Wong	Alethea Capital, Alexandria Venture Investments, Boxer Capital, Brace Pharma Capital, Cormorant Asset Management, EcoR1 Capital, Eli Lilly and Company, Logos Capital, Partner Fund Management, Perceptive Advisors, ST Pharm, Takeda Ventures
Nov 1, 2019	Shape Therapeutics	$36.0M Series A	New Enterprise Associates	8VC, Flucas Ventures, Highbury Group, Menlo Ventures, Ravelin Capital, Sofinnova Investments, VZVC, Debra Miller
Sep 1, 2019	Edgewise Therapeutics	$50.0M Series B	U.S. Venture Partners, Ken Harrison	5AM Ventures, Carol Gallagher, Robert Garland, Nextech Invest, OrbiMed, Osage University Partners, The Column Group, Debra Miller, Robert Jackson, New Leaf Venture Partners
Sep 5, 2018	4D Molecular Therapeutics	$90.0M Series B	Viking Global Investors	Tony Yao, Berkeley Catalyst Fund, BVF Partners, Chiesi Ventures, Janus Henderson Investors, Mirae Asset, Perceptive Advisors, Ridgeback Capital Investments
Feb 27, 2017	Exonics Therapeutics	$5.0M Seed	Debra Miller	—